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switch enhancing phosphatidylinositol (PI) and phospho-
inositides, which are crucial for the formation of vacuolar 
membranes and endocytosis. Lipid changes occur indepen-
dently of caspase activation and appear to be exacerbated 
by caspase inhibition. Conversely, inhibition or compensa-
tion of PC deficiency attenuates endocytosis, endosome-
mitochondria mixing and the induction of cell death. 
Deficiency of receptor interacting protein, RIP, also limits 
the specific changes in membrane lipids that are induced 
by Fas activation, with parallel reduction of endocytosis. 
Thus, Fas activation rapidly changes the interconversion of 
PC and PI, which then drives enhanced endocytosis, thus 
likely propagating death signaling from the cell surface to 
mitochondria and other organelles.
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Abstract Once activated, some surface receptors promote 
membrane movements that open new portals of endocy-
tosis, in part to facilitate the internalization of their acti-
vated complexes. The prototypic death receptor Fas (CD95/
Apo1) promotes a wave of enhanced endocytosis that 
induces a transient intermixing of endosomes with mito-
chondria in cells that require mitochondria to amplify death 
signaling. This initiates a global alteration in membrane 
traffic that originates from changes in key membrane lipids 
occurring in the endoplasmic reticulum (ER). We have 
focused the current study on specific lipid changes occur-
ring early after Fas ligation. We analyzed the interaction 
between endosomes and mitochondria in Jurkat T cells by 
nanospray-Time-of-flight (ToF) Mass Spectrometry. Imme-
diately after Fas ligation, we found a transient wave of lipid 
changes that drives a subpopulation of early endosomes to 
merge with mitochondria. The earliest event appears to be a 
decrease of phosphatidylcholine (PC), linked to a metabolic 
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Introduction
The program of cell death involves biochemical changes in 
diverse intracellular organelles, in particular mitochondria 
[1]. Mitochondria are centrally positioned in the intrinsic 
pathway as well as the extrinsic, death receptor-mediated 
pathway of apoptosis [2]. In the majority of mamma-
lian cell, death receptors require mitochondrial factors to 
amplify the activation of caspases [3, 4]. In these cells, usu-
ally called type II, engagement of mitochondria lags behind 
the rapid assembly of the signaling complex produced by 
receptor ligation at the cell surface [3, 5, 6].
Mitochondria also form a nexus in emerging connections 
between death receptor signaling and caspase-independent 
forms of cell death [7, 8]. For example, cardiolipin, a mem-
brane lipid specific to mitochondria [9], is altered follow-
ing activation of death receptors in a process fundamentally 
independent of caspases [10–14]. Alteration of membrane 
lipids may facilitate the engagement of mitochondria, since 
cardiolipin is specifically targeted by the caspase-cleaved 
form of Bid. Bid is a ubiquitous pro-apoptotic protein of 
the Bcl-2 family that functions as the major cytosolic link 
between apical caspases and mitochondrial membranes [5, 
7, 15]. How cardiolipin becomes involved in the pro-apop-
totic action of Bid and other Bcl-2 proteins has remained 
unclear [15, 16], considering that cardiolipin is predomi-
nantly located within the inner mitochondrial membrane, 
whereas pro-apoptotic proteins act on the outer mitochon-
drial membrane [2].
One possibility to explain how mitochondrial mem-
brane lipids partake to the pro-apoptotic process is that 
other membrane organelles become intermixed with mito-
chondria during death signaling [7]. The dynamic aspects 
of intracellular organelles form part of membrane traffic, 
which follows diverse portals of endocytosis [17]. Emerg-
ing evidence indicates that death receptors are rapidly inter-
nalised after ligation, involving endocytic processes com-
mon to other receptors [6, 18–20]. The complexes formed 
by activated death receptors maintain signaling after inter-
nalization, thus using the early traffic of endocytic vesi-
cles as a vehicle for intracellular communication [19–21]. 
The role of endosomal vesicles in death receptor-mediated 
apoptosis has been well characterized in type I cells, which 
do not require mitochondrial amplification of the caspase 
cascade [18, 20]. However, it is unclear how endocytic 
changes are linked to the propagation of death signaling 
[20, 22]. Further evidence also suggests that endosomal 
traffic may contribute to the engagement of mitochondria 
and other intracellular organelles in type II cells [23, 24]. 
In this work we have explored the mechanism of endocytic 
changes associated with the activation of Fas, the proto-
typic death receptor. The endocytic cycle requires specific 
changes in membrane lipids, with transient accumulation 
of phosphatidylinositol-3-phosphate (PI3P)—the signature 
lipid of early endosomes and an essential component of the 
membranes of all vacuoles [25, 26]. We have thus focused 
our studies on specific lipid changes occurring early after 
Fas ligation. Following prior investigations [12, 23], we 
have studied the interaction between endosomes and mito-
chondria in type II cells that are physiologically sensitive to 
Fas-mediated cell death. Immediately after Fas ligation, we 
found a transient wave of lipid changes that drives a sub-
population of early endosomes to merge with mitochondria, 
initiating a global alteration of the membrane traffic that 
precedes and possibly expand the caspase cascade of cell 
destruction.
Materials and methods
Reagents
Fluorescent probes and assays were purchased from Molec-
ular Probes/Invitrogen (Eugene, OR). Tricyclodecan-9-yl 
xanthogenate (D609) was from Biomol (Plymouth Meet-
ing, PA) and benzyloxycarbonyl-Val-Ala-Asp-fluorometh-
ylketone (z-VAD) from Alexis (San Diego, CA). Recom-
binant superFasL was purchased from Apotech (Lausanne, 
Switzerland). Other chemicals were from Sigma (St. Louis, 
MO), GibCo and Fisher (Loughborough, UK).
Cell culture
Jurkat T cells were cultured in RPMI 1640 medium 
(Sigma–Aldrich, Milan, Italy) containing 10% foetal calf 
serum (FCS) plus 100 units/ml penicillin, 10 mg/ml strep-
tomycin, at 37 °C in humified 5%  CO2 atmosphere.
Treatments
Cells were treated with 0.25  µg/ml recombinant FasL 
(Apotech, Lausanne, Switzerland) for 30 min and 60 min 
at 37 °C, in the absence of serum and the levels of apopto-
sis were evaluated by bi-parametric flow cytometry analy-
sis [27], using a FACScan instrument (Becton Dickinson, 
Franklin Lakes, NJ, USA). In parallel experiments, cells 
untreated or treated with 0.25  µg/ml recombinant FasL, 
were incubated with z-VAD (a pan-caspases inhibitor) 
or D609 (a polyvalent phospholipase inhibitor) for 1  h at 
37 °C.
Cell‑death assay
Quantification of apoptosis was performed by flow cytom-
etry after double cell staining with fluorescein isothio-
cyanate (FITC)–conjugated annexin V and Trypan blue 
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(Sigma), which allows discrimination among early apop-
totic, late apoptotic, and necrotic cells.
Mitochondrial membrane potential in living cells
The mitochondrial membrane potential (MMP) of controls 
and treated cells was studied by using 5–5′,6–6′-tetrachloro-
1,1′,3,3′-tetraethylbenzimidazol-carbocyanine iodide probe 
(JC-1, Molecular Probes). In line with this method, living 
cells were stained with 10 μM of JC-1. Tetramethylrhoda-
mine ester 1 μM (TMRM), (Molecular Probes, red fluores-
cence) was also used to confirm data obtained by JC-1 (not 
shown).
Analysis of cytochrome c release
For cytochrome c release assays, 1 × 106 cells were seeded 
in 6-well plates and after 24 h were treated with FasL, in 
the presence or absence of zVAD or D-609. Cells were then 
collected by centrifugation. After washing three times in 
PBS, cells were suspended in 250  μl of hypotonic buffer 
(2 mM  MgCl2, 10 mM KCl, 10 mM Tris–HCl, pH 7.6) sup-
plemented with complete protease inhibitor mixture (Roche 
Applied Science), and incubated on ice for 10  min. Cells 
were homogenized with a Teflon homogenizer with B-type 
pestle and, after addition of an equal volume of mitochon-
dria buffer (400 mM sucrose, 10 mM TES, 400 μM EGTA, 
pH 7.2), centrifuged twice for 10  min at 900×g at 4 °C. 
The supernatant was recovered and further centrifuged for 
15 min at 17,000×g at 4 °C. The pellet fraction was consid-
ered to be the mitochondria, and the supernatant was the 
cytosol. Release of cytochrome c was assessed by using a 
specific ELISA kit (R&D Systems, Minneapolis, MN) and 
expressed as ng/ml.
TEM analysis
Jurkat cells, untreated or treated with 0.25 µg/ml recombi-
nant FasL, were fixed in 2.5% cacodylate-buffered (0.2 M, 
pH 7.2) glutaraldehyde for 20 min at room temperature and 
post-fixed in 1%  OsO4 in cacodylate buffer for 1 h at room 
temperature and processed as stated elsewhere [27]. Serial 
ultrathin sections were collected on 200-mesh grids, coun-
terstained with uranyl acetate and lead citrate, and then 
analysed with a Philips 208 electron microscope at 80 kV.
Organelle isolation
Isotonic subcellular fractionation was carried out essen-
tially as previously described by Sorice et  al. [12] and 
illustrated in Supplementary Material Fig.  1. In detail, 
1.5 × 108 cells, untreated or treated with 0.25 µg/ml recom-
binant FasL for 30 and 60 min at 37 °C were homogenized 
in 1 ml of cold isolation buffer (0.25 M Mannitol, 1 mM 
EDTA, 10 mM K-Hepes, 0.2% BSA, pH 7.4) containing a 
cocktail of protease inhibitors (Sigma). After a brief cen-
trifugation at 600×g, pellet and supernatant were com-
bined, rehomogenized and centrifuged at 800×g for 10 min 
at 4 °C. The pellet was discarded and the supernatant was 
further centrifuged at 10,000×g for 10  min at 4 °C. The 
pellets kept as fraction P10, was suspended in assay buffer 
(0.12  M mannitol, 0.08  M KCl, 1  mM EDTA, 20  mM 
K-Hepes, pH 7.4), or recentrifuged to obtain mitochondria. 
The supernatants were centrifuged at 22,000×g for 50 min 
to separate light membranes (fraction P20) from the cytosol 
(fraction S20).
After centrifugation at 9000×g for 15  min at 4 °C, the 
pellet was resuspended in 0.5  ml of assay buffer, centri-
fuged at 10,000×g for 10  min, and then resuspended in 
25 µl of assay buffer with protease inhibitors (Supplemen-
tary Fig. 1). The purity of mitochondria (P10) and ER-rich 
fraction (P20) were verified by specific markers using anti-
TOMM20 (mouse, Abcam, Cambridge, MA) and anti-
prolyl-4-hydroxylase subunit β (P4HB) (rabbit, Abcam) 
respectively. After evaluation of the protein concentration 
by Bradford Dye Reagent assay (Bio-Rad, Hercules, CA, 
USA), fractions were stored at −80 °C.
Immunoblotting
Cell lysates and subcellular samples were separated by 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE). The 
proteins were electrophoretically transferred onto polyvi-
nyldene difluoride (PVDF) membranes (Bio-Rad). Mem-
branes were blocked with 5% defatted dried milk in Tris-
buffered saline (TBS), containing 0.05% Tween 20 and 
probed with rabbit anti-early endosomal antigen 1 (EEA1) 
polyclonal antibody (R&D Systems Inc., Minneapolis, MN, 
USA), polyclonal antibody anti-VDAC/porin and anti-p115 
(Santa Cruz Biotechnologies, CA, USA). Bound antibodies 
were visualized with horseradish peroxidase (HRP)-conju-
gated anti-rabbit IgG and immunoreactivity was assessed 
by chemiluminescence reaction, using the ECL Western 
detection system (Amersham Buckinghamshire, UK).
Quantitative analysis of immunoblot images was carried 
out using NIH Image 1.62 as software (Mac OS X, Apple 
Computer International).
Lipid extraction and analysis by MS
After isolation, membrane subcellular fractions were sub-
jected to lipid extraction in methanol:chloroform 1:1, as 
described earlier [11]. Samples were further mixed with 
0.5 ml of 0.15 M NaCl and the organic phase was separated 
by centrifugation, dried under nitrogen, dissolved in chlo-
roform, and centrifuged to remove any insoluble material. 
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Lipid samples were analysed by nanospray-Time-of-flight 
(ToF) Mass Spectrometry (MS) using either a  QSTAR® 
(Applied Biosystems, Toronto, Canada), LCT or Q-TOF 
Micro (Micromass, Manchester, UK) instrument, usually 
set in positive ion mode. The cleared lipid extracts were 
infused into the mass spectrometer using capillary voltage 
at 2.250 V and sample cone at 35 V. The MS and MS/MS 
data were acquired in continuum mode over the range of 
100–2000 m/z; for MS/MS the range depended on the m/z 
of the precursor ion.
For semiquantitative evaluation of lipid peaks, we used 
a variety of internal reference lipid ions that maintained 
equivalent relationships within multiple spectra of the 
same sample. Some of these ions showed little variation 
between control and apoptotic samples. These reference 
ions included sphingomyelin at 703.4  m/z [43] and the 
dominant phosphatidylethanolamine species, palmitoyl, 
stearoyl-phosphatidylethanolamine, at 768.6 m/z [13].
Concentration of phospholipids was evaluated from the 
content of organic phosphate, also using malachite green 
using our own modification of the PLD assay. Three exper-
iments were repeated in each investigation.
Organelle staining
For mitochondria or endosomes detection, cells were spe-
cifically stained either in solution [for IVM analysis, cf. 
27] or after attachment to polylysine-coated coverslips [28] 
with Mitotracker red for 1  h at 37 °C. After incubation, 
cells were fixed with 4% paraformaldehyde in PBS (w/v 
in PBS) for 30 min at room temperature and then permea-
bilized with 0.5% Triton X-100 in PBS for 5 min at room 
temperature. Cells were stained with anti-EEA1 polyclonal 
antibodies for 1 h at 4 °C, followed by three washes in PBS 
and addition of Alexa Fluor 488-conjugated anti-rabbit for 
additional 30 min. See figure legends for further details of 
fluorescence microscopy imaging.
Analysis of the effects of Er‑PC on phospholipids 
biosynthesis and on endocytosis
Cells were treated with 20 µM erucyl-phosphocholine (Er-
PC) for 1 h at 37 °C. After washing, pellets were subjected 
to organelle isolation (P20 and P10 fractions) and then to 
lipid extraction for MS analysis as described above. Alter-
natively, cells were subjected to fluorescence-based assays. 
Briefly, endocytosis was evaluated following the fluores-
cence changes of FM1-43 [28, 29] in either a plate reader 
(Fluoroskan Ascent, Thermo, Basingstoke, UK) or a spec-
trofluorimeter (Perkin-Elmer LC50: excitation at 470  nm 
and emission at 565–580  nm), using 5 × 105  cells/ml in a 
modified Ringer buffer (RB, containing 145  mM NaCl, 
4.5 mM KCl, 2 mM  MgCl2, 1 mM  CaCl2, 5 mM K-Hepes, 
pH 7.4, and 10  mM glucose) and 2–4  µM FM1-43. The 
activity of cathepsin L was measured using the substrate 
rhodamine110-FR-bisamide [30].
Receptor‑interacting protein (RIP) antisense modified 
cell line
Mammalian expression vectors were constructed to express 
a RIP antisense RNA, according to Pimentel-Muinos [31].
Data analysis and statistics
For flow cytometry studies all samples were analyzed by 
a dual-laser FACScalibur cytometer equipped with a 488 
argon laser and with a 635 red diode laser. At least 20.000 
events/sample were acquired. Data were recorded and sta-
tistically analyzed with a Macintosh computer using Cell-
QuestPro Software. Col-lected data analysis was carried 
out by using ANOVA 2-way test for repeated samples by 
using Graphpad Prism software corrected for multiple 
comparisons by the Bonferroni procedure. All the data 
reported in this paper were verified in at least three differ-
ent experiments and reported as mean ± standard deviation 
(SD). Only P values of less than 0.01 were considered as 
significant.
Results
Morphological evidence of vacuole‑mitochondrial 
contacts after Fas activation in Jurkat cells
We previously found morphological evidence indicating 
a global polarization of endocytic membranes toward the 
Golgi apparatus, after Fas stimulation in T lymphoma cells 
[32]. Following these results, we next looked for possible 
intracellular changes, i.e. intermixing of endosomes with 
mitochondria, induced by FasL treatment in Jurkat cells 
using TEM analysis. After 1 h of FasL treatment we noted 
differences in terms of organelle distribution (Fig.  1b), 
as compared to untreated control cells (Fig.  1a). In par-
ticular, several mitochondria appeared to be approaching 
by vacuoles of different shape and origin. In some cases 
vacuoles, deriving from cellular membrane, seem to move 
toward mitochondria as observable in Fig.  1b (arrow). In 
other cases vacuoles appear to be in close contact with 
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mitochondria (Fig.  1c, arrow). Of note, these cytological 
changes occurred before any morphological sign of apopto-
sis and resembled in part the vacuole fusion with mitochon-
dria reported earlier in liver treated with TNFα [33].
Changes in membrane lipids induced by FasL
Starting from previously reported changes in phospho-
inositides following PI3P elevation and from analysis 
on lipid extracts from Jurkat mitochondria containing 
abundant lipid metabolites related to PC [26, 34], we 
investigated the progressive alteration of membrane lipids 
during Fas signaling in Jurkat cells. After separating cell 
membranes with a subfractionation procedure [23], we 
found that FasL treatment (30 and 60 min) induced a sig-
nificant change in the relative levels of long PC and PI 
species and their phosphorylated derivatives in ER-rich 
fraction P20 (Fig.  2a). Maximal increase of the PI spe-
cies at 977 m/z (predominantly C40:6 Na3) and selected 
PIP species like those at 1005 and 1009 m/z (C38:2 Na3 
and C40:6 Na2, respectively) occurred after 60  min of 
FasL treatment (Fig.  2a, arrow). Of note, the increase 
Fig. 1  Morphological evidence of endosome-mitochondria con-
tacts after Fas activation TEM images of Jurkat cells untreated (a) or 
treated (b, c) with FasL. Ultrastructural analysis after FasL treatment 
revealed an increasing number of vacuoles as well as their increasing 
proximity to mitochondria. An untreated control cell is shown in (a). 
A vacuole migrating from cellular membrane toward mitochondria is 
displayed in (b, arrow), whereas a vacuole in close proximity to mito-
chondria is shown in (c, arrow). Bars 0.5 µm. d Morphometric analy-
ses were performed by counting the number of vesicles in cell cyto-
plasm and evaluating the percentage of cells in which we observed 
some (n < 5, grey columns) or many (n > 5, black columns) vesicles. 
Three different grids for sample, for a total of at least 40 cells, were 
analyzed at the same magnification (×16,000). *p < 0.01 FasL-treated 
cells versus control cells
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Fig. 2  Lipid changes and increase of early endosomes after FasL 
treatment. a MS profile of the lipid extracts from the P20 frac-
tion of untreated (control) and FasL-treated Jurkat cells for 30 or 
60  min. MS spectra of the PI/PIP region (>900  m/z) are amplified 
fivefold in treated cells; b detection of EEA1 in subcellular frac-
tions of untreated or FasL-treated cells for 30 or 60 min. Mitochon-
dria and P20 fraction were separated by SDS-PAGE and probed with 
anti-EEA1 at 4 °C overnight, using films (Fuji MI-NP 30) that allow 
enhanced quantitative resolution. Results obtained in a representative 
experiment are shown. Purity of subcellular preparations and loading 
control were evaluated by western blot, using antibodies versus mito-
chondrial marker TOMM20, and ER marker P4HB. Densitometric 
EEA1/TOMM20 ratios and EEA1/P4HB ratios are shown in the bot-
tom panel. Results represent the mean ± SD from three independent 
experiments. *p < 0.01 FasL-treated cells versus control cells. c Over-
all projection of images from 56 z-sections obtained after 10 cycles of 
deconvolution by using a Deltavision RT system (Applied Precision) 
coupled to an automated Olympus IX71 microscope (×60 objec-
tive). Cells were first stained with 50  nM Mitotracker red (MTR), 
then attached to coverslips, fixed and permeabilised for EEA1 immu-
nostaining, followed by Alexa Fluor488-conjugated anti-mouse. Note 
the increase in number and intensity of EEA1-positive vacuoles after 
FasL treatment (central and right panel). After 60  min-FasL treat-
ment (right panel) mitochondrial fragmentation, typical of the execu-
tion phase of apoptosis, was observed
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in these PI and PIP species closely matched the loss of 
SA-PC C38:4 (peaks at 810 and 832  m/z) and other 
long unsaturated phospholipids (Fig.  2a). These related 
changes appeared to be transient, consistent with the tran-
sient association of EEA1 to the membranes of the same 
fraction P20 (Fig.  2b). Indeed, a progressive increase of 
EEA1 was detected in the mitochondrial fraction of FasL 
treated cells (30 and 60 min, Fig. 2b). These results were 
also confirmed by densitometric analyses (Fig.  2b, bot-
tom panel). Purity of subcellular preparations P10 and 
P20, were verified by TOMM20, a typical mitochondrial 
marker, and P4HB, an ER-associated protein marker, 
respectively. Immunofluorescence analysis confirmed this 
possibility, since after 30 min of FasL treatment there was 
a clear increase in the number and size of vacuoles posi-
tive for EEA1, some of which showed close spatial rela-
tions with mitochondria as indicated by discrete staining 
overlaps in deconvolution microscopy images. Virtually 
the same pattern was observed after 60 min of FasL treat-
ment (Fig. 2c).
Pharmacological modulation of Fas‑induced changes 
in membrane lipids
To verify the role of membrane lipids during Fas-medi-
ated signaling, we analysed the whole spectrum of cellu-
lar membrane lipids after FasL treatment of Jurkat T cells, 
in the presence of either z-VAD to block all caspases (note 
that only caspase-8 was significantly activated under the 
conditions used [23]) and that has been shown to hinder 
apoptosis and MPP loss induced by FasL in human lymph-
oblastoid T-cell lines CEM [24] or D609, a polyvalent 
phospholipase inhibitor that has been previously shown to 
protect cells from Fas- and TRAIL-mediated cell death [13, 
35] by modulating both endocytosis and cell death.
Within a comprehensive study of the membrane lipids of 
lymphoma cells, we concentrated on fraction P10 because 
it contained most cellular mitochondria but with variable 
levels of other organelles after FasL treatment. Significant 
depletion (59 ± 17%) of the major palmitoyl-oleoyl PC 
C34:1 was detected already after 30  min of FasL treat-
ment, concomitantly with an average 50% loss of CL, as 
previously reported for TRAIL [13]. Block of caspases 
with z-VAD exacerbated the loss of PC induced by FasL 
and led to the accumulation of PC catabolites like oleate 
and diacylglycerol, DAG (fragment at 585 m/z, Fig. 3a). In 
essence, the profile of Fas-induced changes in membrane 
lipids indicated an overall imbalance between PC degra-
dation and biosynthesis that was substantially reduced by 
D609 (Fig.  3a). The simplest possibility explaining this 
imbalance was that FasL treatment induced upstream inhi-
bition of CTP:phosphocholine cytidylyltransferase (CCT), 
i.e. the critical enzyme of PC biosynthesis [36]. The MS 
profile of mitochondrial lipid extract from Jurkat control 
cells (without FasL) have already been shown in our previ-
ous papers [11, 14]. In particular, mitochondria from Jur-
kat cells, similar to those from most other cells, including 
mouse hepatocytes, contain a large complement of PC, 
which constitutes the dominant phospholipid of intracellu-
lar membranes. A by-product ion at 204 m/z (most proba-
bly the sodiated adduct of glyceryl-dimethylene-phosphate) 
appeared to be the most intense ion in the MS spectra 
obtained from the Q-TOF MS analysis.
Importantly, pre-treatment with D609 significantly 
reduced the depletion and remodeling of PC species that 
was induced by FasL (Fig. 3a). By considering the whole 
spectrum of major phospholipids and their metabolites, 
D609 attenuated the effects of Fas activation, producing 
changes of intermediate intensity with respect to those 
observed with FasL alone and FasL plus z-VAD. These 
related changes appeared to be transient, consistent with 
the transient association of EEA1 to the membranes of the 
same fraction P20. Of note, redistribution of EEA1 in P10 
and P20 fractions induced by FasL occurred independently 
of caspase activation as evident in presence of z-VAD; in 
particular, caspase inhibition enhanced the association of 
EEA1 with mitochondria (Fig.  3b, right panel), as previ-
ously reported [23]. These results were also confirmed by 
densitometric analyses (Fig.  3b, bottom panel). Interest-
ingly, Fas-mediated decrease of p115 in ER-rich mem-
branes was observed (Fig.  3c), suggesting that p115 pro-
tein is dynamically associated with Golgi membranes and 
enhances the key enzymatic activity of PC metabolism, 
CCT, by direct binding to the enzyme [37].
Hence, the cumulative analysis of membrane lipids of 
FasL-treated Jurkat cells indicated an upstream alteration in 
the metabolic equilibrium between PC and PI initiated at 
the ER level. This alteration then reverberated onto mito-
chondrial membranes and could easily reflect an upstream 
inhibition of CCT, a possibility that was further reinforced 
by the Fas-mediated decrease of p115 in ER-rich mem-
branes as showed by western blot analysis and confirmed 
by densitometric analyses (Fig. 3c).
As expected, cytofluorimetric analysis revealed a sig-
nificant increase of apoptosis after FasL triggering with 
respect to untreated cells (Fig. 3d, bar graph in left panel 
and Supplementary Fig.  2, left column). According with 
this, the analysis of mitochondrial membrane potential, 
performed after cell staining with JC-1, showed a depo-
larization of mitochondrial membrane in a significant 
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(p < 0.01) percentage of FasL-triggered cells in comparison 
to control cells (Fig. 3d, bar graph in central panel and Sup-
plementary Fig.  2, right column). In agreement with the 
biochemical data, cell pre-treatment with zVAD or D-609 
was able to significantly prevent (p < 0.01) either apopto-
sis or mitochondrial membrane depolarization (Fig. 3d, bar 
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graph in left and central panels and Supplementary Fig. 2). 
Cell treatment with zVAD or D-609 alone did not induce 
any neither apoptosis nor mitochondrial membrane altera-
tion (data not shown). These data were also corroborated by 
quantitative analysis of cytocrome c performed by ELISA, 
which highlighted as the release of cytochrome c induced 
by FasL was significantly inhibited by pre-treatment with 
zVAD or D-609 (Fig. 3d, bar graph in right panel).
Modelling of Fas‑induced changes in membrane lipids: 
Er‑PC treatment of Jurkat cells
Given the above indication for a Fas-induced dysregulation 
of PC-PI homeostasis, we next examined whether phar-
macological inhibition of de novo biosynthesis of PC [38, 
39] would reproduce the signature lipid changes observed 
in FasL-treated cells. T cells represent a good model to 
manipulate PC biosynthesis, since it is known that in these 
cells the expression of the alternative pathway of PE meth-
ylation is not effective [36]. Thus, we treated cells with 
cytotoxic concentrations of erucyl-phosphocholine (Er-PC) 
(Fig.  4). Er-PC is an anticancer alkyl-ether-lysophospho-
lipid [40], that is closely related to edelphosine and equally 
depresses PC biosynthesis, primarily by inhibiting CCT 
[41, 42].
We first verified that Er-PC treatment enhanced endocy-
tosis as described for similar compounds in other systems 
(Fig.  4a, left panel). Interestingly, Er-PC also enhanced 
the endocytic uptake of fluorescent dextran (Fig. 4a, right 
panel), as previously reported for genetic defects of CCT 
[39]. The membrane lipids of the same Er-PC-treated cells 
showed clear changes arising from strong inhibition of PC 
biosynthesis and metabolic alteration thereof, which appear 
to have altered the relative composition of major phospho-
lipids (Fig.  4b). In particular, Er-PC induced an overall 
depletion of PC species accompanied by a large increase 
in the ion at 708 m/z, assigned to a byproduct of sodiated 
phosphatidic acid (PA)—a key precursor of PI [38]—and 
various sodiated, long PI species and related PIP species 
(Fig.  4b). Moreover, loss of long PC species was associ-
ated with the concomitant elevation in PI species having 
the same long unsaturated acyl chains (e.g. the decrease in 
C40:5 PC at 836 m/z in parallel to the increase of C40:5 
PI-Na3 at 979 m/z). Consequently, acute inhibition of PC 
biosynthesis induced a metabolic shift from PC to long 
unsaturated PI species, including phosphatides instrumen-
tal to membrane traffic. We thus surmise that the enhanced 
membrane traffic due to the documented alteration in cel-
lular membrane lipids may also affect the propagation of 
the apoptotic wave emanating from Fas receptor activation. 
Moreover, Er-PC-treated cells showed vacuoles in close 
proximity, or even merging with mitochondria, as revealed 
by TEM images (Fig. 4c, arrows in right panel), similarly 
to what observed in FasL treated cells.
RIP‑deficiency attenuates lipid changes induced 
by FasL
Because pharmacological manipulation with D609 led to 
a complete inhibition of the global changes in membrane 
traffic that are elicited by Fas stimulation, and consider-
ing the broad spectrum of potential targets of D609, it 
was unclear which D609-sensitive step could be related 
to the earliest lipid changes driving endocytosis. Fol-
lowing previous findings showing a role of RIP in vac-
uole-dependent cell death [43], we decided to follow the 
genetic approach of down-regulating RIP expression to 
dissect key lipid changes and their effect on Fas-enhanced 
endocytosis.
We reasoned that if RIP were fundamental for modu-
lating lipid interconnections, its genetic deficiency might 
produce recognizable changes in steady-state levels of PC, 
PI and CL even in resting cells. We thus examined the MS 
profile of all membrane lipids of Jurkat cells in which the 
dominant isoform of RIP was genetically ablated as showed 
Fig. 3  MS of lipids. a Semi-quantitative analysis of electrospray 
MS spectra of mitochondrial lipid ions as obtained under conditions 
minimizing the contribution of sodiated species (P10 fraction, i.e. 
unwashed mitochondria). The spectral data are represented as relative 
levels normalized to the intensity of the major PE species, 768 m/z, 
an internal reference ion displaying little changes during early apop-
tosis [13]. Computed values are the mean of 2–4 measurements and 
are reduced (DAG) or amplified (PIP and CL) to be comprised in 
the same scale. Note the FasL-induced depletion of short chain and 
medium PC species, the loss of major CL species (right) and the spe-
cific depletion of PI in the D609-treated sample (arrow). b Upper 
panel subcellular distribution of endosome markers. P10, P20 and 
S20 fractions obtained from untreated and FasL-treated cells in the 
absence or in the presence of z-VAD or D-609, were separated by 
SDS-PAGE and probed with anti-EEA1 or anti-VDAC/porin at 4 °C 
overnight. Results obtained in a representative experiment are shown. 
Bar graph in the bottom panel shows densitometric analysis in a rep-
resentative experiment. Loading control was evaluated by coomassie 
blue staining. c Western blot analysis of p115 associated with equal 
loadings of untreated and FasL-treated cells in ER-enriched mem-
branes (fraction P20). Results obtained in a representative experiment 
are shown. Bar graph in the right panel shows densitometric analy-
sis. Results represent the mean ± SD from three independent experi-
ments. *p < 0.01 FasL-treated cells vs control cells. d Bar graphs 
showing the analyses of apoptosis (left panel), MPP (central panel) 
and cytochrome c release (right panel). Values reported represent the 
percentage ± SD of data obtained from three different experiments. 
*p < 0.01 z-VAD or D-609 + FasL-treated cells versus FasL-treated 
cells
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by western blot analysis (Fig.  5a). In untreated cells, the 
absence of RIP enhanced the basal levels of the same short 
and medium PC species that were rapidly depleted follow-
ing FasL treatment for 30 min Jurkat cells (Fig.  5b, c). It 
also modified the metabolic balance between PI and CL in 
favour of the latter (the dominant trioleoyl-arachidoyl-3Na 
CL at 1542 m/z increased by 50%), thus showing the oppo-
site effect than treatment with FasL (Fig. 5c).
In complementary studies we observed that RIP-defi-
cient cells exhibited no significant change in the caspase-
stimulated dispersal of secretory endomembranes follow-
ing the initial burst of endocytosis (Fig. 6). As shown in 
Fig.  6, the global changes in HPA-labelled membranes 
[dual HPA assay, cf. 23] that are normally induced by 
FasL treatment were affected by RIP deficiency. Indeed, 
RIP deficiency only affected surface and endocytic 
changes enhanced by FasL treatment which occurred 
beyond the levels observed in untreated cells (either wt or 
RIP-deficient).
Bypass of PC deficit rectifies early effects of FasL
To provide complementary evidence for the role of 
PC deficiency in the observed organelle scrambling, 
we tested whether exogenous lysophosphatidylcho-
line (LPC) could reduce phenotypic changes induced 
by FasL treatment (Fig. 7). It has been long established 
that defective PC biosynthesis (induced either geneti-
cally or pharmacologically) is effectively rectified by 
supplementing cells with exogenous LPC (Fig. 7a). This 
lysolipid is rapidly taken up and converted into intracel-
lular PC, thereby bypassing the upstream block in PC 
production [36, 42, 44]. Exogenous LPC also protects 
from the apoptotic effects induced of PC deficiency [42, 
44], as suggested here by quantitative evaluation of cell 
viability (Fig. 7b).
Discussion
We previously observed that the interaction of death 
receptor CD95/Fas with its physiological ligand, FasL, 
enhances endocytosis before the occurrence of apopto-
sis and independently of caspase activation in T cells 
[23, 24]. In particular, FasL binding is able to trigger a 
directional “movement” of some early and late endosomes 
towards mitochondria. We hypothesized that a sort of 
endosomal-stress can occur in the very early phases of 
receptor-mediated apoptosis in T cells. This may contrib-
ute to the complex organelle-crosstalk leading to the prop-
agation of the signals to appropriate downstream effec-
tors (e.g., to mitochondria) [45]. We show here that this 
propagation initiates a global alteration in membrane traf-
fic that originates from changes in key membrane lipids 
occurring in the endoplasmic reticulum (ER). The earli-
est event appears to be a decrease of phosphatidylcholine 
(PC), linked to a metabolic switch enhancing phosphati-
dylinositol (PI) and phosphoinositides, which are crucial 
for the formation of vacuolar membranes and endocyto-
sis. Lipid changes occur independently of caspase activa-
tion and appear to be exacerbated by caspase inhibition. 
Conversely, inhibition or compensation of PC deficiency 
attenuates endocytosis, endosome-mitochondria mixing 
and the induction of cell death.
In essence, the profile of Fas-induced changes in 
membrane lipids indicated an overall imbalance between 
PC degradation and biosynthesis that was substantially 
reduced by D609. The simplest possibility explaining this 
imbalance is that Fas activation induces upstream inhibi-
tion of CCT, i.e. the critical enzyme of PC biosynthesis 
[36]. Importantly, pre-treatment with the lipase inhibitor 
D609 significantly reduced the depletion and remodeling 
of PC species that was induced by FasL. Additional, yet 
unknown targets of DISC-activated enzymes could be 
involved in the global changes of membrane traffic we 
have documented here. On the basis of our results with 
D609, we hypothesize enzymes responsible for the rapid 
accumulation of PI and its phosphorylated forms are that 
among these targets. In type II cells that are physiologi-
cally sensitive to FasL-mediated death, DISC-activated 
enzymes may induce an early alteration of proteins that 
are critical for normal membrane traffic, thus promoting 
the transient dispersal of secretory organelles and their 
surface exposure.
For example, deficiency of receptor interacting pro-
tein (RIP) also attenuates the specific changes in mem-
brane lipids that are induced by Fas activation, with paral-
lel reduction of endocytosis. However, further studies are 
needed to confirm this observation.
Fig. 4  Modelling of membrane lipid changes in Jurkat cells with 
Er-PC. a The left panel shows on-line endocytosis of Jurkat cells 
incubated for 20 min after treatment with 20 µM Er-PC followed by 
a wash in full medium and re-suspension in Ringer buffer. The right 
panel shows flow cytometry evaluation of endocytosis in cells treated 
with 20 µM Er-PC for 1 h in the absence of serum. Results obtained 
in a representative experiment are shown. Bar graph in the right 
panel shows densitometric analysis. Results represent the mean ± SD 
from three independent experiments. *p < 0.01 Er-PC-treated cells 
versus control cells. b MS analysis of the lipid extract of total mem-
branes (cumulative P20-P10 fractions) of the same cells as those used 
in (a). Note the depletion of PC and concomitant increase of long PI 
and various PI(3)P species, which are shown magnified sixfold in the 
right. c TEM image of Jurkat control cell (left panel) and treated cells 
with 20 µM Er-PC for 1 h showing the close contact between vacu-
oles and mitochondria (right panel)
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Fig. 5  MS analysis of mito-
chondrial membranes of RIP-
deficient cells. a Western blot 
analysis of RIP in RIP-deficient 
 (RIP−/−) and the corresponding 
parental wild-type clone (wt) 
of Jurkat cells. Results obtained 
in a representative experiment 
from three independent experi-
ments are shown. b MS analysis 
of membrane lipids (cumulative 
P20-P10 fractions) of parental 
wild-type and  RIP−/− cells. The 
right part is magnified 36-fold. 
c MS profile of the membrane 
lipids extracted from fraction 
P20 from  RIP−/− cells treated 
with FasL for 30 min (top 
panel). The bottom panel shows 
the reference MS profile of the 
lipids from the same fraction 
of wild type Jurkat cells. Note 
the increase in DAG species 
without loss of major PC spe-
cies with concomitant increase 
in long PI species, contrary to 
what happens in wild-type cells 
treated with FasL
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In conclusion, we suggest two fundamental phases in the 
complex changes of membrane traffic that are induced by 
Fas ligation:
1. a rapid rise in pinocytosis, propagating form the cell 
surface to its organelles including mitochondria, pro-
ceeding in a way which is caspase-independent but 
RIP-dependent;
2. a subsequent dispersal of intracellular organelles that is 
RIP independent but caspase-dependent.
Thus, Fas activation rapidly changes the interconver-
sion of PC and PI, which then drives enhanced endocyto-
sis, propagating death signalling from the cell surface to 
mitochondria and other organelles. This metabolic change 
is likely to be responsible for the movement of a subpopu-
lation of early endosomes in proximity with mitochondria, 
contributing to the complex organelle-crosstalk that finally 
leads to cell demise [32, 45, 46].
Fig. 6  Dual labelling of Golgi 
and endosomes and different 
effects of RIP deficiency and 
D609. Dual staining of mobile 
membrane elements was accom-
plished by incubating parental 
wild-type and  RIP−/− cells with 
Texas-red-conjugated HPA 
(external, 20 mg/ml) simultane-
ously to FasL. Subsequent to 
fixation, cells were quenched 
with unlabelled HPA (52 mg/
ml), permeabilized and then 
stained with Alexa Fluor 488-
HPA (static HPA, 2 mg/ml 
for 5 min). After washing and 
mounting, images were obtained 
with Deltavision RT deconvolu-
tion microscopy
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